Singapore, Nov. 11 -- based Holmusk has announced a collaboration with the healthcare business sector of Merck, to support patients and physicians in Asia-Pacific (APAC) with a holistic treatment approach for prediabetes and diabetes.

This partnership involves Holmusk's GlycoLeap, a leading mobile digital therapeutics platform that utilizes a highly data-driven approach to deliver personalized dietary feedback, interactive educational lessons, and 1-1 guidance with a qualified health coach. The goal is to help patients achieve weight loss and improved blood glucose control.

Lifestyle and behavior change are foundational for good management of patients with prediabetes & diabetes, yet often difficult to implement by healthcare providers ...